Genomic engineering of biosynthetic pathways leading to increased nadph
AssigneeZymergen Inc.
InventorsShawn MANCHESTER, Benjamin MASON, Alexi GORANOV
Life of this patent
Estimating the term…
Loading patent…
AssigneeZymergen Inc.
InventorsShawn MANCHESTER, Benjamin MASON, Alexi GORANOV
Estimating the term…
The disclosure relates to host cells having altered NADPH availability, allowing for increased production of compounds produced using NADPH, and methods of use thereof. NADPH availability is altered by one or more of: expressing an altered GAPDH, expressing a variant glutamate dehydrogenase (gdh), aspartate semialdehyde dehydrogenase (asd), dihydropicolinate reductase (dapB), and meso-diaminopimelate dehydrogenase (ddh), expressing a novel nicotinamide nucleotide transhydrogenase, expressing a novel threonine aldolase, and expressing or modulating the expression of a pyruvate carboxylase in the host cells.
-76. (canceled)
A recombinant microbial cell comprising:
Dependencies are inferred from the claim text.